126 related articles for article (PubMed ID: 29389408)
1. Epidermal Growth Factor Receptor Inhibitor Induced Trichomegaly and Poliosis.
Goyal S; Uwaydat SH
Ophthalmology; 2018 Feb; 125(2):294. PubMed ID: 29389408
[No Abstract] [Full Text] [Related]
2. Trichomegaly and poliosis of the eyelashes during cetuximab treatment of metastatic colorectal cancer.
Rodriguez NA; Ascaso FJ
J Clin Oncol; 2011 Jun; 29(18):e532-3. PubMed ID: 21483009
[No Abstract] [Full Text] [Related]
3. Trichomegaly of the eyelashes after colorectal cancer treatment with the epidermal growth factor receptor inhibitor cetuximab.
Bambury R; McCaffrey JA
Clin Colorectal Cancer; 2009 Oct; 8(4):235. PubMed ID: 19822516
[No Abstract] [Full Text] [Related]
4. Cetuximab-associated elongation of the eyelashes: case report and review of eyelash trichomegaly secondary to epidermal growth factor receptor inhibitors.
Cohen PR; Escudier SM; Kurzrock R
Am J Clin Dermatol; 2011 Feb; 12(1):63-7. PubMed ID: 20726623
[TBL] [Abstract][Full Text] [Related]
5. Ocular side effects and trichomegaly of eyelashes induced by erlotinib: a case report and review of the literature.
Celik T; Kosker M
Cont Lens Anterior Eye; 2015 Feb; 38(1):59-60. PubMed ID: 25249292
[TBL] [Abstract][Full Text] [Related]
6. [Panitumumab-induced trichomegaly].
Vañó-Galván S; Longo F; Grillo E; Jaén P
Med Clin (Barc); 2013 Apr; 140(8):e15. PubMed ID: 23490492
[No Abstract] [Full Text] [Related]
7. Trichomegaly of the eyelashes during therapy with epidermal growth factor receptor inhibitors: report of 3 cases.
Fabbrocini G; Panariello L; Cacciapuoti S; Bianca D; Ayala F
Dermatitis; 2012; 23(5):237-8. PubMed ID: 23010833
[TBL] [Abstract][Full Text] [Related]
8. Severe Onycholysis and Eyelash Trichomegaly Following Use of New Selective Pan-FGFR Inhibitors.
Bétrian S; Gomez-Roca C; Vigarios E; Delord JP; Sibaud V
JAMA Dermatol; 2017 Jul; 153(7):723-725. PubMed ID: 28538953
[No Abstract] [Full Text] [Related]
9. Eyelash trichomegaly induced by erlotinib for metastatic lung cancer.
Chan JYY; Kwok TYT; Yuen HKL
Hong Kong Med J; 2021 Feb; 27(1):60.e1-60.e3. PubMed ID: 33568562
[No Abstract] [Full Text] [Related]
10. Persisting corneal erosion under cetuximab (Erbitux) treatment (epidermal growth factor receptor antibody).
Foerster CG; Cursiefen C; Kruse FE
Cornea; 2008 Jun; 27(5):612-4. PubMed ID: 18520515
[TBL] [Abstract][Full Text] [Related]
11. Trichomegaly of the eyelashes following treatment with cetuximab.
Vaccaro M; Pollicino A; Barbuzza O; Guarneri B
Clin Exp Dermatol; 2009 Apr; 34(3):402-3. PubMed ID: 19120397
[No Abstract] [Full Text] [Related]
12. [Dry eye].
Cursiefen C
Ophthalmologe; 2013 Jun; 110(6):498-9. PubMed ID: 23783991
[No Abstract] [Full Text] [Related]
13. Trichomegaly of the eyelashes following treatment with cetuximab.
Bouché O; Brixi-Benmansour H; Bertin A; Perceau G; Lagarde S
Ann Oncol; 2005 Oct; 16(10):1711-2. PubMed ID: 15972283
[No Abstract] [Full Text] [Related]
14. Erlotinib-induced trichomegaly in a male patient with pancreatic cancer.
Saif MW; Gnanaraj J
Cutan Ocul Toxicol; 2010 Mar; 29(1):62-6. PubMed ID: 19954400
[TBL] [Abstract][Full Text] [Related]
15. A case of trichomegaly of the eyelashes and facial hypertrichosis induced by erlotinib (Tarceva).
Márquez G; Herrera-Acosta E; Vidal I; Galvany L; Iglesias M; Umbert P
Int J Dermatol; 2009 Jan; 48(1):97-8. PubMed ID: 19126063
[No Abstract] [Full Text] [Related]
16. Trichomegaly of the eyelashes after lung cancer treatment with the epidermal growth factor receptor inhibitor erlotinib.
Braiteh F; Kurzrock R; Johnson FM
J Clin Oncol; 2008 Jul; 26(20):3460-2. PubMed ID: 18612164
[No Abstract] [Full Text] [Related]
17. Acquired trichomegaly and symptomatic external ocular changes in patients receiving epidermal growth factor receptor inhibitors: case reports and a review of literature.
Zhang G; Basti S; Jampol LM
Cornea; 2007 Aug; 26(7):858-60. PubMed ID: 17667622
[TBL] [Abstract][Full Text] [Related]
18. Progressive trichomegaly.
Vano-Galvan S; Moreno-Martin P; Jaén P
Neth J Med; 2009 Jan; 67(1):35-6. PubMed ID: 19155549
[No Abstract] [Full Text] [Related]
19. Acquired trichomegaly: trichomegaly secondary to erlotinib.
Medina Mendez CA; Ma PC; Singh AD
JAMA Ophthalmol; 2014 Sep; 132(9):1051. PubMed ID: 25078467
[No Abstract] [Full Text] [Related]
20. [Trichomegaly due to cetuximab].
Bagazgoitia L; Aboín S; Beà S; Muñoz E
Med Clin (Barc); 2009 Sep; 133(8):323. PubMed ID: 19540538
[No Abstract] [Full Text] [Related]
[Next] [New Search]
